中国重大抑郁症药物治疗算法计划:有好处还是没有好处?
Yuncheng Zhu1,2,3, Fang Wang4, Fan Wang2
1Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, 200083, China.
Heliyon
|November 3, 2023
概括
在重大抑郁症 (MDD) 中预测抗抑郁药治疗结果是复杂的. 临床特征,而不是算法引导治疗 (AGT),似乎是中国患者治疗反应的关键.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药物基因组学 药物基因组学
背景情况:
- 大型抑郁症 (MDD) 构成了全球重大健康挑战.
- 识别抗抑郁药治疗结果的预测因素对于个性化医学至关重要.
- 患有MDD的中国患者具有独特的人口和临床特征.
研究的目的:
- 研究算法指导治疗 (AGT) 和用于预测中国MDD患者抗抑郁药治疗结果的临床特征.
- 为了确定与抗抑郁药不响应相关的风险因素.
- 为了比较AGT与通常治疗 (TAU) 的疗效.
主要方法:
- 在三个月后,对581名治疗反应者和406名无反应者的前性研究.
- 响应组与不响应组之间的社会人口统计因素,临床特征和评分尺度的比较.
- 使用了后勤回归和卡普兰-梅尔生存分析.
主要成果:
- 非响应者 (URA) 的婚姻状况较低,焦虑困扰率较低,并具有较高的并发病率.
- 焦虑特征与URA正相关,而自主症状与URA负相关.
- 在AGT和TAU之间,在症状缓解的时间上没有统计学上显著的差异.
结论:
- 临床因素显著影响抗抑郁药治疗反应和MDD的遵守.
- 了解症状集群可能会改善治疗结果.
- AGT没有显示出与TAU相比的好处,这表明需要个性化方法.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Psychosis: Goals of Pharmacotherapy
143
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
143
Depressive Disorders: MDD and Dysthymia
138
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
138


